TWiV 1124: Clinical update with Dr. Daniel Griffin - podcast episode cover

TWiV 1124: Clinical update with Dr. Daniel Griffin

Jun 22, 202440 minEp. 1124
--:--
--:--
Listen in podcast apps:
Metacast
Spotify
Youtube
RSS

Episode description

In his weekly clinical update, Dr. Griffin reviews the recent statistics on SARS-CoV-2 infection, before discussing methods for sterilizing filtering facepieces, an update to the fall COVID boosters, the emergency use application of a pre-exposure prophylactic and where to find it and drug interaction database, convalescent plasma, the effectiveness of the monoclonal antibody sotrovimab against Omicron variants, what to do when healthcare workers succumb to SARS-CoV-2 infection, the need for better nursing resources, how survivors of COVID-19-associated ARDS exhibited sustained elevation in endothelial dysfunction biomarkers, correlating with the severity of impaired gas exchange, reactivation of latent CMV as a consequence of a SARS-CoV-2 infection, identification of variables that might impact or predict a person’s time to recovery from an acute SARS-CoV-2 infection and if COVID-19 patients really have olfactory dysfunction more often than normally smelling individuals.

Subscribe (free): Apple PodcastsGoogle PodcastsRSSemail

Become a patron of TWiV!

Links for this episode

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to [email protected]

For the best experience, listen in Metacast app for iOS or Android
Open in Metacast
TWiV 1124: Clinical update with Dr. Daniel Griffin | This Week in Virology podcast - Listen or read transcript on Metacast